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What is already known about this topic?
 Keratinocyte or non-melanoma skin cancer is the commonest cancer worldwide and 
current guidelines underestimate incomplete excision rates. These are based on 
extrapolated data from Mohs micrographic surgery, rather than primary clinical studies. 
What does this study add?
 The proportion of incomplete excision was 11·0% for BCCs and 9·4% for SCCs. When 
based on clinical data the rate is double the proportion suggested by national guidelines. 
This data suggests that excision by specialists may reduce treatment failure. 
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Summary
Background 
Keratinocyte or non-melanoma skin cancer (NMSC) is the commonest malignancy worldwide. 
Usual treatment is surgical excision. Current guidelines underestimate incomplete excision rates. 
Objectives
We aimed to determine the risk of incomplete excision of NMSCs through a systematic review 
and meta-analysis of primary clinical studies. 
Methods
A PRISMA-compliant systematic review and meta-analysis was performed using methodology 
proposed by Cochrane. A comprehensive search strategy was applied to MEDLINE, Embase, 
Scopus, CINAHL, EMCare, Cochrane Library and the grey literature (January 2000–27th November 
2019). All studies were included except studies on Mohs micrographic surgery, frozen section or 
biopsies. Abstract screening and data extraction were performed in duplicate. The risk of bias 
was assessed using a tool for prevalence/incidence studies. The primary outcome was the 
proportion of incomplete surgical excisions. A random effects model for pooling of binominal 
data was used. Differences between proportions were assessed by sub-group meta-analysis and 
meta regression which were presented as risk ratios. PROSPERO CRD42019157936.
Results
Searching identified 3477 records, with 110 studies included, comprising 53 796 patients with 
106 832 basal cell carcinomas (BCC) and 21 569 squamous cell carcinomas (SCC). The proportion 
of incomplete excisions for BCC was 11·0% (95% CI 9·7-12·4%) and for SCC 9·4% (95% CI 7·6-
11·4%). Incomplete excisions by specialty were: dermatology 6·2% BCCs, 4·7% SCCs; plastic 
surgery 9·4% BCCs, 8·2% SCCs; general practitioners 20·4% BCCs, 19·9% SCCs. The risk of 
incomplete excision for general practitioners was four times that of dermatologists for both BCC 
(RR 3·9 [95% CI 2·0-7·3]) and SCC (RR 4·8 [95% CI 1·0-22·8]). Studies were heterogenous (I2=98%) 
and at high risk of bias.
 A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved
Conclusions
The proportion of incomplete excisions is higher than previously reported. Excisions performed 
by specialists may lower the risk of incomplete excision.
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Introduction
Keratinocyte or non-melanoma skin cancer (NMSC) is an umbrella term which includes basal cell 
carcinoma (BCC) and cutaneous squamous cell carcinoma (SCC) as the most prevalent subtypes. 
They are the commonest cancers worldwide and in the United Kingdom (UK) they account for 
20% of all new malignancies.1 The UK incidence is 124-148 per 100 000 person years,2 and is 
projected to rise due to increased reporting and historic exposure to ultraviolet radiation. In 
2020, skin cancer is estimated to cost the NHS over £180 million per annum.3
The mainstay of treatment is complete surgical excision. For BCC, the likelihood of recurrence 
has been well established to be directly related to the adequacy of excision; 1%4, 5 of BCCs recur 
where margins are clear, compared to 31-41% recurrence where margins are involved.6, 7 The 
same data for SCC is lacking, however given its metastatic potential which is reported at 5-47%,8 
complete excision is desirable. Incomplete excisions may require further surgery or increased 
surveillance which burdens patients and healthcare systems, increasing the costs and morbidity 
of skin cancer care.3
In the UK, skin cancer excisions are predominantly performed in secondary care.9 The joint 
guidance from the National Institute for Health and Care Excellence (NICE) and the British 
Association of Dermatologists (BAD) includes recommendations regarding surgical margins.10, 11 
Their recommendations are based upon data from studies using Mohs micrographic surgery, 
which was extrapolated to estimate the expected proportion of incomplete excision with 
different peripheral margins12-15 (i.e. 4–5mm peripheral margin is suggested to confer clear 
margins in 95% of small, well-defined BCCs.)11 This gave the quoted figure of 5% incomplete 
excision rate, however this is not based on clinical studies using surgical excision. Two large-scale 
national audits of BCC and SCC excisions by UK dermatologists have reported different 
proportions of incomplete excision of between 2.3% to 3%.16, 17
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The objective of this study was to systematically evaluate observational studies that present the 
risk of incomplete surgical excision in adults with NMSC worldwide. Secondarily, we aimed to 
determine if other factors were associated with the risk of incomplete excision. 
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Materials and methods
Search strategy and selection criteria
This systematic review and meta-analysis was conducted in accordance with our peer-reviewed 
published protocol,18 registered prospectively on PROSPERO (CRD42019157936) and reported in 
adherence to Cochrane and PRISMA standards.19 
Any study reporting the proportion of incomplete excisions for BCCs and SCCs in adult patients (≥ 
18 years old) was eligible, regardless of publication status, language or setting.  We excluded 
reviews, case reports, and case series with fewer than 50 patients as these studies may be 
underpowered to detect incomplete excision rates, and including underpowered studies may 
reduce the reliability of the meta-analysis. Studies using Mohs micrographic surgery or with 
intra-operative frozen section were excluded as the margin assessment takes place immediately 
during these techniques, and wider excisions are performed at the same sitting if tumour 
extends to a margin. Consequently, the incomplete excision rate for Mohs micrographic and 
intra-operative frozen section is theoretically close to 0% and including these studies would bias 
our meta-analysis to a lower proportion of incomplete excision. Furthermore, Mohs micrographic 
surgery is considered a separate procedure to standard wide local excision by many surgeons 
and not comparable. Studies reporting lesions expected to have incomplete margins (incision, 
shave or punch biopsies) were also excluded. Studies reporting on metastatic SCCs, and those 
located on the perineum and external genitalia (e.g. anal, vulvar and penile SCC) were not 
included as these patients are often treated via a different pathway to cutaneous lesions and 
require different management. 
In accordance with our published protocol,18 a structured search of MEDLINE, Embase, Scopus, 
CINAHL, EMCare, and Cochrane Library was undertaken from January 2000 onwards. The search 
was performed on 27th November 2019 however several more recent publications were 
identified after the search through hand-searching of included references and included. We 
limited studies to those conducted post-2000 as skin cancer care has progressed over time and 
data more than 20 years old is unlikely to be representative of current clinical practice. 
Additionally, the grey literature was searched using Open Grey, dissertation databases (e.g. Open A
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Access Theses and Dissertations) and clinical trial registries (e.g. World Health Organization 
International Clinical Trials Registry Platform). We hand-searched the reference lists of included 
studies, relevant reviews, national clinical practice guidelines, and other relevant documents to 
identify cited articles not captured by electronic searches. Two authors (GSN, ALK or JPT) 
independently dual screened all titles and abstracts and obtained full text for references 
potentially meeting the inclusion criteria in Rayyan.20 Translations were obtained for non-English 
articles using Google translate. The final decision about inclusion was based on the full texts. 
Discrepancies between reviewers were resolved through discussion. 
Data analysis 
Data were independently extracted onto a bespoke electronic sheet by two authors (GSN, ALK or 
JPT). Data on study demographics and design, patient demographics, time period of study, and 
risk of bias were collected. The primary outcome was the proportion of incomplete excisions 
(defined as residual tumour at either the peripheral or deep margin on histological examination). 
‘Closely’ or ‘near to’ excised lesions were considered as completely excised. Secondary outcomes 
were other factors which might be related to the risk of incomplete excision such as the 
discipline of the operating surgeon, the location of lesions, the types of reconstruction 
performed (e.g. skin grafts and flaps), the histological components,10, 21 the use of loupe 
magnification, and year of study publication. Eleven study authors were contacted about missing 
data and responses were received from seven. 
The risk of bias was assessed twice and independently by three authors (GSN, ALK and JPT) using 
a risk of bias tool for studies of prevalence/incidence.22 This comprises of signalling questions and 
a summary assessment, which assesses the external validity of the study (selection and non-
response bias) and the internal validity (measurement bias and bias related to analysis). 
Responses for individual items were either high or low risk of bias, and if there was insufficient 
data to decide the default was high risk of bias. The summary assessment evaluates the overall 
risk of study bias and is based on the rater’s subjective judgement, given responses to the 
preceding questions, which is in line with Cochrane approaches.23, 24 Response options for the 
summary assessment were low, moderate, or high risk of bias. A
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The pooled proportion of incomplete surgical excision of BCCs and SCCs were estimated using 
the metaprop package25 in Stata/MP v15 (StataCorp). Dersimonian and Laird random-effects 
were used given the clinical heterogeneity. The Freeman-Tukey arcsine transformation was used 
to stabilise the variance. 95% confidence intervals (CI) around the study-specific and pooled 
proportion were computed using the score-test statistic.26 Variations in the logit of the 
proportion of incomplete excisions by operator, use of loupes, year of publication, study design 
and the overall risk of bias were further explored by subgroup meta-analyses and meta-
regression using the metareg procedure.27 The results of the meta-regressions were back 
transformed and are presented as risk ratios (RR). To account for the inflated type 1 error rates 
associated with meta-regression in the presence of many covariates and heterogeneity, p-values 
were corrected using the Monte Carlo permutation test with 20,000 iterations.28 Three sensitivity 
analysis were undertaken. Firstly, where studies judged to be at high risk of bias, secondly when 
conference abstracts were excluded (as the limited word count of this format prevents proper 
methodological assessment of the study) and finally if study design (prospective/retrospective) 
affected the risk of incomplete excision. Further subgroup analyses of pooled NMSC (all BCCs and 
SCCs) were undertaken to address the secondary objectives as reconstruction of a defect is not 
specific to a type of skin cancer and lesions with a preclinical diagnosis of BCC or SCC are often 
found to be histologically different. We explored the proportion of incomplete excision by the 
overall risk of bias (high, moderate or low), study design (prospective vs. retrospective), the 
method of reconstruction, the proportion of lesions on the head and neck, use of loupes and 
year of study publication. Statistical heterogeneity was assessed by I2 which corresponds with the 
proportion of total variation due to inter-study heterogeneity and by p-values for inter-study 
heterogeneity and overall.29 A z-test (and the corresponding p-values) assessed whether the 
observed proportion was different from zero percent.  
In order to assess possible small-study effects (or publication bias across studies), we produced a 
funnel plot using metafunnel. 
Differences from the protocolA
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To accurately estimate the proportion of incomplete excision, we used the Freeman-Tukey 
arcsine transformation, rather than logit transformation, to stabilise the variances of proportions 
close to zero. 
Data on histological components could not be extracted due to only a subsection of criteria being 
reported or was not reported for the majority of studies. 
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Results
Of the 3477 citations identified by the search strategy, 110 studies16, 30-138 met the inclusion 
criteria (Figure 1). The characteristics of included studies are summarised in Table 1 and detailed 
in Supplementary Table 2.
A total of 106 832 BCC and 21 569 SCC excisions were included. These were excised from 53 796 
patients across all studies (25 studies did not report the number of patients, instead reporting 
the number of lesions only).16, 17, 34, 49, 59, 60, 62, 68, 69, 71-74, 78, 82, 96, 104, 107, 109, 112, 115, 120, 133, 135, 136 The 
mean age of patients undergoing BCC excision was 67·4 years (SD 14.9) and for SCC excision was 
70·9 years (SD 14·1). Most patients were male (BCC 55·7% and SCC 65·1%). 
Serious bias was present in the data, especially selection bias which might have been due to the 
retrospective design of the majority (82%) of studies. Selection bias was primarily due to the 
exclusion of lesions at higher risk of incomplete excision (e.g. previously incomplete) and 
including only a subset of patients (e.g. using Mohs micrographic surgery for more challenging 
cases). A minority of studies included consecutive excisions. Many studies did not include 
sufficient information on why participants were excluded. A definition and/or statement that 
lesions were examined by a histopathologist were absent in 38% and 28% of studies, respectively 
although It is very unlikely that studies from the last 20 years are not reported by a 
histopathologist. Errors and inconsistencies were identified in 12% of studies in either the 
numerator, denominator or differing figures throughout the text. Studies which were reported as 
conference abstracts only were often judged to be at a higher risk of bias than full papers. The 
risk of bias summary plot is shown in Figure 2. The individual risk of bias for each study is 
included in the Supplementary Figure 1.
The total proportion of incomplete excisions for BCCs was 11·0% (95% CI 9·7-12·4%) and for SCCs 
was 9·4% (7·6-11·4%). When analysed by the operating specialty, dermatology had the lowest 
proportion of incomplete excisions and general practitioners had the highest (Figure 3 and 4, 
study-level estimates in Supplementary Figures 2-7.) Meta-regression showed that general 
practitioners were more likely to incompletely excise BCCs than dermatologists (RR 3·9 [95% CI A
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2·0-7·3] p<0·001, permuted p=0·002) and plastic surgeons (RR 2·4 [95% CI 1·4-4·2] p=0·003, 
permuted p=<0·001). Similarly, general practitioners had a higher proportion of incomplete SCC 
excisions than dermatologists (RR 4·8 [95% CI 1·0-22·8] p=0·05, permuted p<0·001) and plastic 
surgeons (RR 2·2 [95% CI 1·2-8·5] p=0·021, permuted p=0·002). Dermatologists had a lower 
proportion of incomplete excisions than plastic surgeons for both BCCs (RR 0·4 [95% CI 0·2-0·7] 
p=0·003, permuted p<0·001) and SCC (RR 0·3 [95% CI 0·1-0·8] p=0·021, permuted p=0·002).
Table 2 shows that plastic surgeons performed more complex reconstructions (skin grafts and 
flaps) than dermatologist for all NMSC. Other surgeons, such as maxillofacial surgeons and 
ophthalmologists, performed a similar proportion of reconstructions. No studies on excisions by 
general practitioners reported how the defects were reconstructed. Plastic surgeons excised a 
larger proportion of lesions from the head and neck compared to dermatologists, who in turn 
excised a higher proportion than general practitioners. 
Intraoperative use of loupes was not associated with a different incomplete excision risk for 
NMSC (RR 1.6 [95% CI 0·3-7·4] p=0·537; Supplementary Figure 8). Over 20 years, there was no 
change in the proportion of incomplete excision NMSC (p=0·904; Supplementary Figure 9).
There was substantial statistical heterogeneity both within and between groups. 
Sensitivity analysis using studies at low overall risk of bias only yielded a very similar proportion 
of incomplete excision of NMSC (10·2% [95% CI 8·5-12·1]; Supplementary Figure 10). The 
proportion of incomplete excisions for NMSC was similar between full papers, abstractions or 
conference materials (RR 1·0 [95% CI 0·7-1·5] p=0.826). Prospective studies reported a lower 
proportion of incomplete excision than others (RR 0·6 [95% CI 0·4-0·9] p=0.034; Supplementary 
Figure 11).
A funnel plot for all studies showed that datapoints are widely dispersed and the scatter is 
asymmetrical (Supplementary Figure 12; Egger’s regression co-efficient 2·26 [95% CI 2·04-2·48] 
p<0·001) which suggests the presence of small-study effects.A
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Discussion
On the basis of 110 clinical studies, we have shown that the proportion of incomplete excisions 
for BCCs is 11·0% and SCCs is 9·4%. There is substantial variation and heterogeneity in the 
observed proportion of incomplete excision, ranging from 4·7 – 20·4% by operator. 
Dermatologists had the lowest proportion of incomplete excisions (6·2% BCCs, 4·7% SCCs) and 
general practitioners had the highest proportion (20·4% BCCs, 19·9% SCCs). Plastic surgeons had 
a slightly higher proportion of incomplete excisions than dermatologists (9·4% BCCs, 8·2% SCCs) 
however a greater proportion of their lesions were located on the head and neck (92·7%), and 
they also performed more complex reconstructions such as skin grafts and flaps, which imply 
that the lesions were likely to be larger or the macroscopic margin was less well defined. The use 
of loupe magnification had no statistically significant effect on the risk of incomplete excisions. 
Our risk estimates for incomplete excision of NMSCs are the most comprehensive to-date and 
should be used to inform the design of future studies and in the consent process for patients 
worldwide. 
This study is limited by the high risk of bias in the majority of studies. More than 1 in 10 studies 
excluded recurrent, previously incomplete and other high-risk lesions from their primary studies. 
Further selection bias through the differential use of Mohs micrographic surgery by specialty and 
country will remove lesions that are at the highest risk of incomplete excision. Finally, standard 
histology using ‘bread-loaf’ techniques only assesses between 0.19% - 2% of specimen 
margins139-141 so consequently, the actual incomplete excision rate in the population is likely to 
be higher than our estimates suggest. Prospective studies were found to be at a lower risk of 
incomplete excision than retrospective studies, which may be due to selection bias caused by 
stricter inclusion criteria of randomised controlled trials than retrospective studies. Evidence of 
publication bias was identified by asymmetry in the funnel plot which is another limitation. 
Whilst there was statistically significant heterogeneity amongst studies, the greatest strength of 
this study is the breadth of data synthesised and readers should consider whether this 
heterogeneity is clinically relevant. A recent systematic review of incomplete SCC excisions 
showed a similar finding to ours (13%)142 but included metastatic disease and fewer cases. A
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Our forest plots and meta-regression identify large differences in the proportion of incomplete 
excisions by different operating groups (Figures 3 and 4). General practitioners are four times as 
likely to incompletely excise NMSC compared to dermatologists (BCC OR 3·9 [95% CI 2·0-7·3], SCC 
OR 4·8 [95% CI 1·0-22·8]). This finding cannot be explained by selection bias, as it seems unlikely 
that general practitioners are excising more complex lesions than those they refer to 
dermatologists. Our data supports the notion that excisions of NMSCs should not be undertaken 
by non-specialists, as they may lack sufficient training and support which translates into a higher 
rate of incomplete excision. Multiple studies have shown that general practitioners with a special 
interest in skin cancer were at a lower risk of incomplete excision than their colleagues,78, 125 so 
we see no reason to restrict excisions to secondary care. It is worth noting that a low risk, truncal 
BCC in an elderly patient that has been incompletely excised may never clinically recur, and 
incomplete excision does not always necessitate further surgery. The low risk for dermatologists 
is likely multi-factorial. The prevalent use of Mohs micrographic surgery by dermatologists is 
effective at removing the highest risk lesions from their caseload, and accordingly they typically 
excise a greater volume of smaller, lower risk lesions. The more complex lesions they encounter 
are referred to plastic surgeons (27-52%101, 143, 144 of skin cancer referrals plastic surgeons receive 
are from dermatologists). In contrast plastic surgeons excised larger lesions, of more aggressive 
subtypes, with indistinct macroscopic borders, and this study accordingly found a higher 
proportion of incomplete excision of BCCs (9·4%) and SCCs (8·2%). This systematic review 
highlights that the current skin cancer pathways are effective, with dermatologists excising large 
numbers of low risk lesions whilst plastic, ophthalmological, and head & neck surgeons deal with 
more difficult lesions which may also require reconstruction. 
Specific anatomical factors also likely play a large role in the risk of incomplete excision. 
Periocular lesions appeared to be at a greater risk as shown by the relatively high risk with 
ophthalmology and plastic surgery studies on this subset of patients.67, 87 Additionally, high-risk 
histological lesions, such as morphoeic BCCs, have been shown to be at higher risk of incomplete 
excision. In this systematic review, due to a lack of reporting of some high-risk elements such as 
peri-neural invasion, it was not possible to extract data on histological factors. Two studies were 
solely on morphoeic BCCs and these reported very different proportions of incomplete excisions A
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of 6%120 and 32%.65 Additionally other factors may impact the proportion of incomplete excision 
which were not explored by this systematic review, such as the grade of the operating surgeon, 
the margin of normal tissue taken and the apriori plan for reconstruction: if the surgeon plans to 
close directly then this may bias the excision towards a smaller margin, whereas when a surgeon 
plans to reconstruct a defect with a skin graft then comparably a more liberal margin may be 
taken. These factors would be best explored using Bayesian techniques. With SCC the margin 
used in different studies was infrequently reported in the larger studies.17, 42, 59, 78, 107, 115, 125, 129 
When it was reported, several studies found no association between wider margins and reduced 
proportion of incomplete excision,92, 130 often as the deep margin was primarily affected.92 
Audits of outcomes following NMSC excisions will undoubtedly continue throughout plastic 
surgery and dermatology units worldwide, of which the majority will never be published. Future 
published studies must be of higher methodological quality and should be prospective and 
include consecutive excisions as a minimum. Multi-centre, national, annual audits such as those 
performed by UK dermatologists16, 17 provide the most useful data and other specialties and 
countries should follow suit. Our study has demonstrated the proportion of incomplete excision 
is substantially higher than previously reported. In light of these findings, guidelines should be 
updated, and action taken to improve the outcomes of the world’s commonest malignancy. 
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Figure legends 
Figure 1: PRISMA flow diagram. (Adapted from Moher D, Liberati A, Tetzlaff J, Altman DG, The 
PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta- Analyses: 
The PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed1000097)
Figure 2: Risk of bias summary graph for included studies. Risk of bias was assessed using a tool 
specifically designed for observational prevalence/incidence studies.22
Figure 3: A forest plot of the summary estimates of the risk of incomplete excision for basal cell 
carcinomas (BCCs) split by specialty. General practitioners were more likely to incompletely A
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excise BCCs than dermatologists (RR 3·9 [2·0-7·3] p<0·001, permuted p=0·002) and plastic 
surgeons (RR 2·4 [1·4-4·2] p=0·003, permuted p=<0·001). Dermatologists had a lower risk of 
incomplete excision than plastic surgeons (RR 0·4 [0·2-0·7] p=0·003, permuted p<0·001).
Figure 4: A forest plot of the summary estimates of the risk of incomplete excision for squamous 
cell carcinomas (SCCs) split by specialty. General practitioners were more likely to incompletely 
excise SCCs than dermatologists (RR 4·8 [1·0-22·8] p=0·05, permuted p<0·001) and plastic 
surgeons (RR 2·2 [1·2-8·5] p=0·021, permuted p=0·002). Dermatologists had a lower risk of 
incomplete excision than plastic surgeons (RR 0·3 [0·1-0·8] p=0·021, permuted p=0·002).
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CHARACTERISTIC NUMBER OF 
STUDIES
PERCENTAGE OF 
ALL STUDIES
Randomised controlled trial 3 3%
Prospective 10 9%
Retrospective 47 43%
Cohort 
Other 7 6%
Prospective 6 6%
Retrospective 33 30%
STUDY DESIGN
Case-series
Other 4 4%
2000 – 2005 5 5%
2006 – 2010 31 28%
2011 – 2015 49 45%
YEAR OF 
PUBLICATION
2016 – 2019 25 23%
Europe 69 63%
Asia 19 17%
Oceania 14 13%
South America 7 6%
COUNTRY OF 
ORIGIN  
North America 1 1%
Plastic surgery 37 34%
Dermatology 22 20%
Maxillofacial surgery 10 9%
General practice 8 7%
Ophthalmology 4 4%
Ear, nose & throat surgery 1 1%
SPECIALTY
Other 28 26%
Full paper 79 72%
Conference abstractions 28 26%
TYPE OF 
PUBLICATION
Other 3 3%
TOTAL 110 100%A
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Table 1: Characteristics of included studies. Cohort and case-series ‘other’ includes studies with 
mixture of prospective and retrospective data collection and those where the text is unclear as to 
whether the data collection was retrospective or prospective. ‘Other’ specialty includes studies 
that reported multiple specialties in the same study. ‘Other’ publication type includes conference 
podium and poster presentations. 
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Table 2: The proportion of lesions excised from the head and neck, and the way all lesions were 
reconstructed from the included studies. How lesions which were excised by general 
practitioners and ear, nose and throat surgeons were reconstructed was not reported in any 
studies. 
PROPORTION OF LESIONS RECONSTRUCTED WITH 
% (95% CI)
SPECIALITY PROPORTION OF 
HEAD AND NECK 
EXCISIONS 
% (95% CI)
Direct closure Skin graft Flap
DERMATOLOGY 84·7 (74·7-92·6) 89·3 (85·5-92·6) 2·9 (1·8-4·4) 6·1 (4·7-7·7)
PLASTIC SURGERY 92·7 (86·2-97·3) 55·5 (42·8-66·8) 16·4 (9·9-24·2) 22·6 (11·6-
36·0)
GENERAL 
PRACTICE
31·0 (20·0-43·1) Not reported
MAXILLOFACIAL 
SURGERY
97·7 (85·2-100) 48·6 (44·2-53·0) 24·6 (21·0-
28·6)
26·8 (23·1-
30·8)
EAR, NOSE AND 
THROAT SURGERY 
100 (96·6, 100) Not reported
OPHTHALMOLOGY 100 (98·8-100) 72·2 (64·9-78·5) 13·0 (8·6-19·0) 11·1 (7·1-16·9)
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PRISMA 2009 Flow Diagram 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Records identified through database searching 
MEDLINE (n = 958), Embase (n = 677), CINAHL (n = 42), EMCare (n = 
69), Scopus (n = 587), Cochrane Library (n = 27), OpenGrey (n = 3), 
OATD (n = 81), WHO ICTRP (n = 1033) 
(n = 3477) 
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Additional records identified 
through other sources 
(n = 5) 
Records after duplicates removed 
(n = 2622) 
Records screened 
(n = 2622) 
Records excluded 
(n = 2385) 
Full-text articles assessed 
for eligibility 
(n = 237) 
Full-text articles 
excluded, with reasons 
Background article (n = 8) 
Duplicate (n = 3) 
< 50 patients (n = 6) 
Data prior to 2000 (n = 20) 
Wrong population (n = 4) 
Wrong intervention (n = 23) 
No data available (n = 45) 
Unable to extract data (n = 16) 
Different definition of involved 
margin (n = 3) 
(n = 128) 
Studies included in 
qualitative synthesis 
(n = 110) 
Studies included in 
quantitative synthesis 
(meta-analysis) 
(n = 110) 
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